*in order to reach demonstrated capacity, one has to meet all the attributes of previous scores.
ANTIMICROBIAL RESISTANCE (Example Target & Desired Impact)
Target: Support work being coordinated by WHO, FAO, and OIE to develop an integrated global package of activities to combat antimicrobial resistance, spanning human, animal, agricultural, food and environmental aspects (i.e. a one-health approach), including: a) Each country has its own national comprehensive plan to combat antimicrobial resistance; b) Strengthen surveillance and laboratory capacity at the national and international level following agreed international standards developed in the framework of the Global Action plan, considering existing standards and; c) Improved conservation of existing treatments and collaboration to support the sustainable development of new antibiotics, alternative treatments, preventive measures and rapid, point-of-care diagnostics, including systems to preserve new antibiotics. As Measured by: (1) Number of comprehensive plans to combat antimicrobial resistance agreed and implemented at a national level, and yearly reporting against progress towards implementation at the international level. (2) Number of countries actively participating in a twinning framework, with countries agreeing to assist other countries in developing and implementing comprehensive activities to combat antimicrobial resistance, including use of support provided by international bodies to improve the monitoring of antimicrobial usage and resistance in humans and animals.
Desired Impact: Decisive and comprehensive action to enhance infection prevention and control activities to prevent the emergence and spread of AMR, especially among drug-resistant bacteria. Nations will strengthen surveillance and laboratory capacity; ensure uninterrupted access to essential antibiotics of assured quality; regulate and promote the rational use of antibiotics in human medicine and in animal husbandry and other fields as appropriate; and support existing initiatives to foster innovations in science and technology for the development of new antimicrobial agents.
